Qube Research & Technologies (QRT)
CERE

Qube Research & Technologies (QRT)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,233,565
Closed -$50.4M – 4353
2024
Q2 		$50.4M Buy
1,233,565
+1,058,035
+603% +$44.1M 0.08% 289
2024
Q1 		$7.42M Buy
+175,530
New +$7.37M 0.01% 1002

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CERE Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 1,233,565 shares — an estimated $50.4M sold.

Qube Research & Technologies (QRT) first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $50.4M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,233,565 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $50.4M.
  • Qube Research & Technologies (QRT) first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $50.4M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.